A receptor-driven platform turning food molecules into measurable metabolic outcomes

 

Olfactive Biosolutions

We discover and formulate food-derived ligands that modulate ectopic chemosensory receptors throughout the body—unlocking drug-like physiology with a consumer-friendly, scalable product format.

Now commercializing Pivit® (metabolic health) while building a pipeline of receptor-validated formulations for major chronic health categories.

What We Do

Food ligands → Human receptor validation → Mechanism-backed formulations → Scalable products + licensing.
Screen Shot 2025-08-27 at 5.31.59 PM

Activating physiological signaling pathways naturally

Olfactive Biosolutions is building a platform that identifies food-derived molecules capable of activating specific chemosensory receptors expressed throughout the body (including in the gut), turning “everyday” compounds into precise triggers of physiological signaling pathways. Our first product Pivit® applies this approach to metabolic health by naturally engaging hormone and satiety signaling—supporting endogenous GLP-1–related pathways and adjacent metabolic circuits—without relying on pharmaceuticals. This is especially important in the GLP-1 era because demand has outstripped access, many people struggle with tolerability or long-term adherence, and the market is rapidly expanding beyond drugs into foods, supplements, and functional ingredients that can help more people participate in the benefits of GLP-1–aligned metabolic support. Olfactive is translating the GLP-1 moment into a scalable, consumer-friendly pathway: leveraging nature’s ligands to activate the body’s own signaling biology.

lab1

Why Now

The market is demanding metabolic solutions that are effective, lower-cost, and easier to adopt.

GLP-1-era consumer behavior has shifted permanently—but most options remain constrained by price, access, tolerability, and persistence. Olfactive is building an alternative path: activate the body’s own signaling through receptor-targeted food ligands—designed for long-term use and broad distribution.

How it Works

We map receptor biology to real-world physiology.

Olfactory and taste receptor families aren’t limited to smell and taste; they also exist throughout the body as ectopic receptors that influence metabolic signaling. We identify food-based ligands that modulate these receptors and translate them into formulations designed to drive measurable outcomes—with a clear mechanism of action.

Built for scale from day one.

Because our starting materials are food-derived molecules, our approach is engineered for global accessibility, repeatable manufacturing, and high-volume distribution across consumer and partner channels.

long lab photo

TruePath® Platform

Our advantage: receptor-first discovery + translation.

Olfactive pairs receptor science with systematic ligand discovery to build formulations that are:

  • Receptor-validated (mechanism backed at the receptor level)
  • Protectable (patented compositions and methods)
  • Repeatable (a platform that generates a pipeline—not one product)

This is not a “supplement approach.” It’s a discovery engine that treats receptor biology as the roadmap to outcomes.

cover food pic

Not another
'Nature's Ozempic'

The GLP-1 era has produced hundreds of supplement brands making big metabolic claims on borrowed ingredients and thin science. You deserve better. Pivit is built on a completely different foundation — and here's what that means for you.

It works through a specific biological mechanism
Food-derived molecules in Pivit activate specialized receptors in your gut — the same receptors that GLP-1 medications like Ozempic target — triggering your body's own hunger and blood sugar hormones. This isn't a broad "metabolic support" claim. It's a specific, documented pathway.

The results were measured, not estimated
Our human study used continuous glucose monitors and tracked outcomes over 12 weeks. Participants lost an average of ~12 lbs. When they paused the product, results stalled. When they restarted, results resumed. That's not marketing — that's cause and effect.

It's made from food ingredients — not synthetic drugs
Pivit uses GRAS (Generally Recognized As Safe) food-derived molecules. No prescription. No injections. No synthetic peptides. The same metabolic effect, through a pathway your body already uses every time you eat.

Patented and Science-Based


Built on issued IP and a growing formulation pipeline, Olfactive has multiple granted U.S. patents covering weight management and blood sugar regulation formulations and methods.

Granted Weight Loss & Blood Sugar (x3 Patents)

Three granted US patents covering Pivit's oral formulations that activate gut receptors to trigger GLP-1 and GIP — the same hormones that regulate hunger and blood sugar. Covers both the method and the specific ingredients. Granted Oct–Dec 2024.

Multiple Hormone Activation (US 12,290,550)

Covers Pivit's ability to trigger four metabolic hormones — GLP-1, PYY, glucagon and GIP — through food-based gut receptors. This matches the most advanced pharmaceutical pipeline currently in clinical trials, but through a natural, OTC pathway. Granted May 2025.

Blood Pressure (x2 Patents)

Separate formulations for managing hypertension and resistant hypertension through the same receptor platform. Granted Oct 2024 and Jan 2025. Pivit's science isn't just about weight — the platform applies across multiple health areas.